Department of Health and Social Care (DHSC) has issued a medicine supply notification for Torasemide 10mg tablets MSN/2024/098 Tier 2 – medium impact Date of issue: 2nd October 2024 Torasemide 10mg tablets are in limited supply until March 2025. Torasemide 5mg tablets remain available and can support a partial increase in demand. Alternative loop diuretics
Read moreThe following price concessions granted in September 2024 have rolled over to October 2024: Drug Pack size Price concession Carbimazole 5mg tablets 100 £1.98 Hydroxocobalamin 1mg/1ml solution for injection ampoules 5 £11.75 Propantheline bromide 15mg tablets 112 £103.50 Please note any rolled over prices can be adjusted upwards if we receive reports from pharmacy owners
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (01/10/2024) announced the following final list of price concessions for September 2024: Drug Pack size Price concession Amantadine 100mg capsules 56 £18.06 Apixaban 2.5mg tablets 60 £14.99 Apixaban
Read moreThe Drug Tariff Category M pricelist for October 2024 has been published on the NHS Business Services Authority (NHSBSA) website. The new October Category M prices include an adjustment for margin of -£9m per quarter, resulting from the combination of: An adjustment informed by the latest results from the margin survey of independent pharmacies An
Read moreThe 2023/24 Annual Report for Community Pharmacy England has been published, setting out the range of work that has been done over the past year on behalf of all community pharmacy owners. This included negotiations on the new Pharmacy First service and support for pharmacy owners with national services; ongoing work to monitor margin
Read moreThe ability of pharmacy owners to achieve the thresholds for the monthly Pharmacy First payment has been an ongoing topic of great concern for pharmacy owners and Community Pharmacy England, particularly as the October increase to 30 clinical pathways got closer. We have been discussing this issue over the last few weeks with the Department
Read moreDrug alert number: EL (24)A/44 Date issued: 30 September 2024 Pfizer Limited is recalling all distributed batches of Oxbryta 500 mg Tablets. Pfizer Limited has informed the MHRA that the product is being withdrawn due to emerging data from clinical trials and registry-based studies: Oxbryta (voxelotor) 500mg Tablets (Pfizer Limited) PLGB 00057/1720 DMRC Number: DMRC-32749585
Read moreThe Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Cefalexin 500mg tablets are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP072 Cefalexin 500mg tablets expires at 23.59pm on Friday 27 September 2024. After this date, any prescriptions for Cefalexin 500mg tablets must be
Read moreCommunity Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 15 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 October 2024. This takes the total
Read moreThe Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 October 2024. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution
Read more
